Harim Holdings (003380) has 33 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩16.9B ($11.7M) in reported transaction value. The earliest filing StockDrifts holds for Harim Holdings is dated 2025-11-13; the most recent is 2026-06-26. Across these filings the average return since disclosure is +62.49%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-06-26 | BUY | Market Buy | 권지은 Kwon Ji-eun | Managing Director | 1.0K | ₩9,130 | +0.0% | ₩9M ($6K) |
| 2026-05-28 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 63.9K | ₩11,330 | +0.0% | ₩724M ($503K) |
| 2026-05-22 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 50.0K | ₩12,170 | -6.9% | ₩609M ($423K) |
| 2026-05-21 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 49.7K | ₩12,060 | -6.0% | ₩599M ($416K) |
| 2026-05-20 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 5.0K | ₩11,750 | -3.6% | ₩58M ($40K) |
| 2026-05-19 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 50.0K | ₩12,070 | -6.1% | ₩604M ($419K) |
| 2026-05-18 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 7.7K | ₩12,300 | -7.9% | ₩95M ($66K) |
| 2026-03-12 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 158.2K | - | - | - |
| 2026-03-11 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 69.3K | - | - | - |
| 2026-03-10 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 17.9K | - | - | - |
| 2026-03-09 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 8.0K | - | - | - |
| 2026-03-06 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 200.0K | - | - | - |
| 2026-03-04 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 15.0K | - | - | - |
| 2026-02-20 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 31.6K | ₩16,660 | +0.8% | ₩526M ($366K) |
| 2026-02-19 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 70.0K | ₩16,640 | +0.9% | ₩1.2B ($809K) |
| 2025-12-12 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 60.0K | ₩12,550 | +33.8% | ₩753M ($523K) |
| 2025-12-11 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 11.3K | ₩11,530 | +45.6% | ₩130M ($90K) |
| 2025-12-10 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 175.0K | ₩8,870 | +89.3% | ₩1.6B ($1.1M) |
| 2025-12-09 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 37.3K | ₩8,710 | +92.8% | ₩325M ($225K) |
| 2025-12-08 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 95.3K | ₩9,120 | +84.1% | ₩869M ($604K) |
| 2025-12-01 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 147.9K | ₩8,380 | +100.4% | ₩1.2B ($861K) |
| 2025-11-28 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 92.9K | ₩8,390 | +100.1% | ₩779M ($541K) |
| 2025-11-27 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 125.6K | ₩8,110 | +107.0% | ₩1.0B ($708K) |
| 2025-11-26 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 102.5K | ₩8,210 | +104.5% | ₩842M ($585K) |
| 2025-11-25 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 84.3K | ₩8,020 | +109.3% | ₩676M ($469K) |
| 2025-11-21 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 83.4K | ₩8,140 | +106.3% | ₩679M ($471K) |
| 2025-11-20 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 43.1K | ₩8,250 | +103.5% | ₩356M ($247K) |
| 2025-11-19 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 85.0K | ₩7,970 | +110.7% | ₩678M ($471K) |
| 2025-11-18 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 135.0K | ₩7,980 | +110.4% | ₩1.1B ($748K) |
| 2025-11-17 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 111.0K | ₩8,320 | +101.8% | ₩924M ($641K) |
| 2025-11-14 | BUY | Market Buy | 권지은 Kwon Ji-eun | moving | 2.5K | ₩8,130 | +106.5% | ₩20M ($14K) |
| 2025-11-14 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 31.0K | ₩8,130 | +106.5% | ₩252M ($175K) |
| 2025-11-13 | BUY | Market Buy | 한국바이오텍 Korea Biotech | - | 43.0K | ₩8,250 | +103.5% | ₩355M ($246K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.